FDA warned Veronvy that its Elily Veronvy weight-loss drops are unapproved new drugs and falsely labeled "FDA APPROVED."
What happened
FDA reviewed the website veronvy.com in October 2024 and found "Elily Veronvy" and "Elily Veronvy 40+" offered for sale in the United States with claims about weight loss, appetite suppression, GLP-1 action and slowed gastric emptying. Because those claims show the products are meant to treat or change the body, FDA treats them as drugs — and no FDA-approved application exists for them. FDA also found the site displaying a blue circle reading "FDA APPROVED" and a statement that the drops were approved by FDA last year, which FDA says is false and misleading.
What FDA found
The products are new drugs sold without an FDA-approved application, which the law requires before an unapproved drug can be sold across state lines.
FD&C Act sections 505(a) and 301(d), 21 U.S.C. 355(a) and 331(d)Website claims that the drops cause weight loss, suppress appetite and act like GLP-1 make the products drugs under the law.
FD&C Act section 201(g)(1), 21 U.S.C. 321(g)(1)The products are not generally recognized as safe and effective for these uses, so they count as "new drugs" that need approval.
FD&C Act section 201(p), 21 U.S.C. 321(p)The labeling is false or misleading because it shows an "FDA APPROVED" badge and says FDA approved the drops last year, when no approval exists.
FD&C Act section 502(a), 21 U.S.C. 352(a)Shipping these misbranded drugs across state lines is a prohibited act.
FD&C Act section 301(a), 21 U.S.C. 331(a)
What FDA wants
FDA asks the company to write back within fifteen working days describing each step taken to fix the violations, how it will prevent them from happening again, and copies of related documents, or to explain why it believes the products are compliant. The reply goes to CDER's Office of Unapproved Drugs and Labeling Compliance by email at FDAADVISORY@fda.hhs.gov.
Who should pay attention
- e-commerce supplement brands that make drug-like weight-loss claims
- companies that display FDA approval badges or logos on product pages
- sellers of "GLP-1 alternative" or metabolic drops
This is a summary. Read the original letter on fda.gov.